Rare bone disease in a newborn child
- Autores: Gabitova N.K.1, Cherezova I.N.1,2
-
Afiliações:
- Kazan State Medical University
- Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan
- Edição: Volume 32, Nº S (2025)
- Páginas: 113-116
- Seção: Clinical case
- URL: https://journals.eco-vector.com/2073-4034/article/view/687889
- DOI: https://doi.org/10.18565/pharmateca.2025.1-s1.113-116
- ID: 687889
Citar
Texto integral



Resumo
Congenital bone, joint, and muscle defects may be a manifestation of genetic syndromes, in which congenital defects extend not only to bones, joints, and muscles, but also to other organs and systems. Brooke syndrome is an autosomal recessive disorder with multiple joint contractures and bone fragility. The disease is associated with pathogenic mutations in the FKBP10 and PLOD2 genes, mapped to chromosomes 17 and 3, respectively. The PLOD2 and FKBP10 genes act during the maturation of type 1 procollagen and contribute to the molecular stability of bone tissue. Mutations in the PLOD2 and FKBP10 genes lead to abnormal bone matrix assembly and abnormal post-translational modifications of type 1 collagen, which determines the pathogenesis of brittle bone disease. The article presents a case of a rare disease with increased bone fragility, multiple congenital contractures and congenital heart defect, genetically identified as Brooke syndrome type 1.
Palavras-chave
Texto integral

Sobre autores
Nailya Gabitova
Kazan State Medical University
Autor responsável pela correspondência
Email: Borismk1@rambler.ru
ORCID ID: 0000-0002-8375-0565
Cand. Sci. (Med.), Associate Professor, Department of Hospital Pediatrics
Rússia, KazanI. Cherezova
Kazan State Medical University; Republican Clinical Hospital of the Ministry of Health of the Republic of Tatarstan
Email: Borismk1@rambler.ru
ORCID ID: 0000-0001-8961-0996
Cand. Sci. (Med.), Associate Professor, Department of Hospital Pediatrics
Rússia, Kazan; KazanBibliografia
- Трофимова С.И., Коченова Е.А., Агранович О.Е. и др. Фенотипическая вариабельность у детей с синдромом Брука 2 типа: клинические наблюдения. Ортопедия, травматология и восстановительная хирургия детского возраста. 2023;11(4): 537–545. [Trofimova S.I., Kochenova E.A., Agranovich O.E., et al. Phenotypic variability in children with Brooke’s syndrome type 2: clinical observations. Pediatric Traumatology, Orthopaedics and Reconstructive Surgery. 2023;11(4):537–545. (In Russ.)]. doi: https://dx.doi.org/10.17816/PTORS569365
- Dayasiri K., Jayaweera H. Arthrogryposis multiplex congenita in a child with congenital fractures: a case report. J Med Case Rep. 2022;16(1):376. doi: https://dx.doi.org/10.1186/s13256-022-03587-1
- Вruck A. Ueber eine seltene form von Erkrankung der Knochen und Gelenke. Dtsch Med Wschr. 1897;23:152–155. doi: https://dx.doi.org/10.1055/s-0029-1204900
- Gistelinck C., Weis M., Rai J., et al. Abnormal bone collagen cross-linking in osteogenesis imperfecta/bruck syndrome caused by compound heterozygous plod2 mutations. JBMR Plus. 2021;5(3):e10454. doi: https://dx.doi.org/10.1002/jbm4.10454
- Kelley B.P., Malfait F., Bonafe L., et al. Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome. J Bone Miner Res. 2011;26:666–672. doi: 10.1002/jbmr.250.
- Otaify G.A., Abdel-Hamid M.S., Hassib N.F., et al. Bruck syndrome in 13 new patients: Identification of five novel FKBP10 and PLOD2 variants and further expansion of the phenotypic spectrum. Am J Med Genet A. 2022;188(6):1815–1825. doi: https://dx.doi.org/10.1002/ajmg.a.62718
- Tan Z., Shek H.T., Chen P., et al. Clinical features and molecular characterization of Chinese patients with FKBP10 variants. Mol Genet Genomic Med. 2023;11(4):e2122. doi: https://dx.doi.org/10.1002/mgg3.2122
- Essawi O.H., Tapaneeyaphan P., Symoens S., et al. New insights on the clinical variability of FKBP10 mutations. Eur J Medical Genetics. 2020;63(9):103980. doi: https://dx.doi.org/10.1016/j.ejmg.2020.103980
- Litman C.D., Rajagopal A., Homan E.P., et al. Connective tissue changes in Fkbp10 - /- mice. Hum Mol Genet. 2014;23(18):4822–4831. doi: https://dx.doi.org/10.1093/hmg/ddu197
- Duran I., Martin J.H., Weis M.A., et al. A chaperone complex formed by HSP47, FKBP65, and BiP modulates telopeptide lysyl hydroxylation of type I procollagen. J Bone Miner Res. 2017;32(6):1309–1319. doi: https://dx.doi.org/10.1002/jbmr.3095
- Shang L., Shi W., Xu Y., et al. A novel compound heterozygous variation in the FKBP10 gene causes Bruck syndrome without congenital contractures: a case report. Heliyon. 2024;10(7):e28680. doi: https://dx.doi.org/10.1016/j.heliyon.2024. e28680
- Terajima M., Taga Y., Nakamura T., et al. Lysyl hydroxylase 2 mediated collagen post-translational modifications and functional outcomes. Sci Rep. 2022;12(1):14256. doi: https://dx.doi.org/10.1038/s41598-022-18165-0
- Saito T., Terajima M., Taga Y., et al. Decrease of lysyl hydroxylase 2 activity causes abnormal collagen molecular phenotypes, defective mineralization and compromised mechanical properties of bone. Bone. 2022;154:116242. doi: https://dx.doi.org/10.1016/j.bone.2021. 116242
- Mumm S., Gottesman G.S., Wenkert D., et al. Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation. Bone. 2020;130:115047. doi: https://dx.doi.org/10.1016/j.bone.2019.115047
- Sandy J.L., Perez D., Goh S., et al. Expanding the phenotype of Bruck syndrome: Severe limb deformity, arthrogryposis, congenital cardiac disease and pulmonary hemorrhage. Am J Med Genet A. 2023; 191(1):265–270. doi: https://dx.doi.org/10.1002/ajmg.a.63007
- Тran C.T., Smet M.E., Forsey J., et al. Bruck syndrome: beyond the obvious. Fetal Diagn Ther. 2022;49(11–12):479–485. doi: https://dx.doi.org/10.1159/000527594
Arquivos suplementares
